Baiya Phytopharm Co., Ltd.


Baiya Phytopharm’s plant-based technology is a cutting-edge solution that is quick, simple, and scalable, aiming to replace biotech’s fermenter with plants.

The platform has the flexibility to produce biopharmaceutical products of interest within weeks rather than months or years, resulting in a faster process and lower cost of research and development for products, such as cosmetic raw materials, diagnostic test kit materials, and therapeutics for cancer and infectious diseases. We have been scaling up our platform from scratch to hatch within our tiny laboratory since founding in 2018. Currently, we have a cGMP facility in Bangkok, Thailand to produce clinical materials of plant-produced protein and can produce up to 5 million doses of COVID-19 vaccine per month.